MOUNTAIN LAKE ACQUISITION CO (MLACR) Stock Fundamental Analysis

NASDAQ:MLACR

0.3199 USD
+0.01 (+3.23%)
Last: Feb 26, 2026, 12:48 PM
Overview Stock Chart Technical Analysis News
Fundamental Rating

2

Overall MLACR gets a fundamental rating of 2 out of 10. We evaluated MLACR against 0 industry peers in the Unkown industry. MLACR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MLACR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year MLACR was profitable.
  • In the past year MLACR has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: MLACR reported negative net income in multiple years.
  • MLACR had a negative operating cash flow in each of the past 5 years.
MLACR Yearly Net Income VS EBIT VS OCF VS FCFMLACR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

1.2 Ratios

Industry RankSector Rank
ROA 2.85%
ROE 2.95%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MLACR Yearly ROA, ROE, ROICMLACR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for MLACR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MLACR Yearly Profit, Operating, Gross MarginsMLACR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • There is no outstanding debt for MLACR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MLACR Yearly Shares OutstandingMLACR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2024 10M 20M 30M
MLACR Yearly Total Debt VS Total AssetsMLACR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2024 50M 100M 150M 200M

2.2 Solvency

  • MLACR has an Altman-Z score of 0.55. This is a bad value and indicates that MLACR is not financially healthy and even has some risk of bankruptcy.
  • There is no outstanding debt for MLACR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.55
ROIC/WACCN/A
WACCN/A
MLACR Yearly LT Debt VS Equity VS FCFMLACR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • MLACR has a Current Ratio of 3.14. This indicates that MLACR is financially healthy and has no problem in meeting its short term obligations.
  • A Quick Ratio of 3.14 indicates that MLACR has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.14
Quick Ratio 3.14
MLACR Yearly Current Assets VS Current LiabilitesMLACR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2024 1M 2M 3M 4M 5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • MLACR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 152.10%, which is quite impressive.
  • MLACR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -46.31% yearly.
EPS 1Y (TTM)152.1%
EPS 3Y-46.31%
EPS 5YN/A
EPS Q2Q%7744.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • MLACR is valuated cheaply with a Price/Earnings ratio of 1.23.
  • When comparing the Price/Earnings ratio of MLACR to the average of the S&P500 Index (27.05), we can say MLACR is valued rather cheaply.
Industry RankSector Rank
PE 1.23
Fwd PE N/A
MLACR Price Earnings VS Forward Price EarningsMLACR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MLACR Per share dataMLACR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MLACR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MOUNTAIN LAKE ACQUISITION CO

NASDAQ:MLACR (2/26/2026, 12:48:56 PM)

0.3199

+0.01 (+3.23%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-10
Earnings (Next)03-10
Inst Owners101.9%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.91M
Revenue(TTM)N/A
Net Income(TTM)6.84M
AnalystsN/A
Price TargetN/A
Short Float %0.02%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.23
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.04
P/tB 0.04
EV/EBITDA N/A
EPS(TTM)0.26
EY81.28%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS7.47
TBVpS7.47
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.61
Profitability
Industry RankSector Rank
ROA 2.85%
ROE 2.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.14
Quick Ratio 3.14
Altman-Z 0.55
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.1%
EPS 3Y-46.31%
EPS 5YN/A
EPS Q2Q%7744.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

MOUNTAIN LAKE ACQUISITION CO / MLACR FAQ

What is the ChartMill fundamental rating of MOUNTAIN LAKE ACQUISITION CO (MLACR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MLACR.


What is the valuation status of MOUNTAIN LAKE ACQUISITION CO (MLACR) stock?

ChartMill assigns a valuation rating of 2 / 10 to MOUNTAIN LAKE ACQUISITION CO (MLACR). This can be considered as Overvalued.


What is the profitability of MLACR stock?

MOUNTAIN LAKE ACQUISITION CO (MLACR) has a profitability rating of 1 / 10.


What is the valuation of MOUNTAIN LAKE ACQUISITION CO based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MOUNTAIN LAKE ACQUISITION CO (MLACR) is 1.23 and the Price/Book (PB) ratio is 0.04.